IMMUNOSENS Co.
Latest round
- Series B
Last raised
- Jul 2023
Total raised
- $8.1M
Investors
- 11
About IMMUNOSENS Co.
Based in Japan, IMMUNOSENS Co. Ltd.Founded in 2018 and headquartered in Suita-shi, Japan, IMMUNOSENS Co. Ltd. develops diagnostic tools that support healthcare professionals in disease management. In November 2025, IMMUNOSENS Co. Ltd. Immunosens specializes in developing and manufacturing advanced diagnostic tools and immunoassay technologies aimed at enhancing disease detection and monitoring. Their core product offerings include innovative assays that leverage proprietary technologies to deliver precise and reliable results for various conditions, including autoimmune disorders and infectious diseases. These products aim to provide healthcare professionals with critical insights that aid in patient management, ultimately improving clinical outcomes.Immunosens generates revenue through a structured model that includes both direct sales and partnerships with healthcare providers and research institutions. Their flagship products are marketed through B2B channels, where healthcare entities procure diagnostic assays as part of their laboratory services. Transactions are facilitated through established frameworks, including volume-based pricing agreements and subscription models for ongoing supply of testing kits and reagents. Long-term contracts with customers ensure a steady revenue stream for the company, reflecting the value provided in terms of accuracy and reliability for diagnostic workflows.
Who invested in IMMUNOSENS Co.
11 investors across 5 rounds
See all investors in IMMUNOSENS Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about IMMUNOSENS Co.
Who invested in IMMUNOSENS Co.?
IMMUNOSENS Co. has 11 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IMMUNOSENS Co. raised?
IMMUNOSENS Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did IMMUNOSENS Co. last raise money?
IMMUNOSENS Co.'s most recent round on record is a Series B, in Jul 2023.
What does IMMUNOSENS Co. do?
IMMUNOSENS Co. is a medical devices & equipment company.
Where is IMMUNOSENS Co. headquartered?
IMMUNOSENS Co. is headquartered in Suita-shi, Japan.
Which VCs invest in companies like IMMUNOSENS Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at IMMUNOSENS Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like IMMUNOSENS Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.